MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Cash Flow Overview

Change in Cash
-$7,444K
Free Cash flow
-$20,552K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
    • Proceeds from maturities of inve...
    • Depreciation expense
    • Prepaid expenses and other curre...
    • Others
Negative Cash Flow Breakdown
    • Purchases of investments
    • Accounts payable
    • Accrued expenses and other curre...
    • Others

Cash Flow
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Net loss
-19,042 -18,985 -18,234 -40,686
Depreciation expense
383 361 349 646
Stock-based compensation expense
2,181 3,091 3,911 7,718
Non-cash operating lease expense
273 265 259 503
Net amortization of premiums and accretion of discounts on investments
-161 -130 34 533
Prepaid expenses and other current assets
-380 756 223 -1,169
Accounts payable
-1,202 1,281 -9 264
Accrued expenses and other liabilities
NaN -3,353 NaN NaN
Accrued expenses and other current liabilities
-506 NaN 1,972 -4,844
Operating lease liabilities
-294 -280 -274 -382
Other assets
NaN -137 NaN NaN
Net cash used in operating activities
-20,538 -15,237 -12,283 -36,145
Purchases of investments
16,859 13,257 33,190 35,284
Proceeds from maturities of investments
30,000 35,000 40,000 74,500
Purchases of property and equipment
14 219 899 551
Net cash provided by investing activities
13,127 21,524 5,911 38,665
Proceeds from exercise of stock options
NaN 0 0 1
Payments of tax withholdings related to vesting of restricted stock units
33 192 117 441
Net cash used in financing activities
-33 -192 -117 -440
Net decrease in cash, cash equivalents, and restricted cash
-7,444 6,095 -6,489 2,080
Cash, cash equivalents and restricted cash at beginning of period
41,702 35,607 40,016 NaN
Cash, cash equivalents and restricted cash at end of period
34,258 41,702 35,607 NaN
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Cash Flow

Proceeds from maturitiesof investments$30,000K Net cash provided byinvesting activities$13,127K Canceled cashflow$16,873K Net decrease incash, cash...-$7,444K Canceled cashflow$13,127K Stock-based compensationexpense$2,181K Depreciation expense$383K Prepaid expenses andother current assets-$380K Non-cash operating leaseexpense$273K Net amortization ofpremiums and accretion of...-$161K Purchases of investments$16,859K Purchases of property andequipment$14K Net cash used inoperating activities-$20,538K Canceled cashflow$3,378K Net cash used infinancing activities-$33K Net loss-$19,042K something is missing-$2,872K Accounts payable-$1,202K Accrued expenses andother current...-$506K Operating leaseliabilities-$294K Payments of taxwithholdings related to...$33K

Acrivon Therapeutics, Inc. (ACRV)

Acrivon Therapeutics, Inc. (ACRV)